학술논문
Safety and immunogenicity of an Ad26.ZEBOV booster vaccine in Human Immunodeficiency Virus positive (HIV+) adults previously vaccinated with the Ad26.ZEBOV, MVA-BN-Filo vaccine regimen against Ebola: A single-arm, open-label Phase II clinical trial in Kenya and Uganda
Document Type
Article
Author
Man-Lik Choi, E.; Foster, J.; Ayieko, P.; Njie, Y.; Kasonia, K.; Edward Connor, N.; Florence, N.; Manno, D.; Lowe, B.; Greenwood, B.; Kaleebu, P.; Watson-Jones, D.; Abu-Baker Mustapher, G.; Anywaine, Z.; Vudriko, T.; Ayoub, K.; Omosa-Manyonyi, G.; Musila Mutua, M.; Ann Mwangi, I.; Mundia Muriuki, M.; Anzala, O.; Katwere, M.; McLean, C.; Luhn, K.; Robinson, C.; Gaddah, A.
Source
In: Vaccine . (Vaccine, 7 December 2023, 41(50):7573-7580)
Subject
Language
English
ISSN
18732518
0264410X
0264410X